Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prodromal Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06957418
What this trial is testing

Alzheimer's Tau Platform: Master Protocol

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer DiseaseProdromal Alzheimer's Disease
Paul S. Aisen 900
Large-scale testing (Phase 3)Study completedNCT03486938
What this trial is testing

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio 164
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Not applicableStudy completedNCT01630525
What this trial is testing

" The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University Hospital, Bordeaux 83
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Testing effectiveness (Phase 2)Ended earlyNCT03289143
What this trial is testing

Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 457
Not applicableLooking for participantsNCT07239310
What this trial is testing

Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease(AD)
Deepsonbio 138
Not applicableUnknownNCT05349318
What this trial is testing

Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease

Who this might be right for
Prodromal Alzheimer's DiseaseCerebral Vascular DisorderMild Cognitive Impairment+1 more
Assaf-Harofeh Medical Center 100
Large-scale testing (Phase 3)Ended earlyNCT01953601
What this trial is testing

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 1,454